Buy MacroGenics Stock | MGNX Stock Price & Latest News | Public
MGNX

MacroGenics

$0.00 (0.00%)Today

    About MGNX

    MacroGenics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing antibody-based therapeutics designed to modulate the human immune response for the treatment of cancer. 2. Its product pipeline includes Margetuximab, Flotetuzum...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.31
    -0.63
    -0.94
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.85

    Actual EPS
    Q4 2020

    Stats

    Market Cap$1,29B
    Volume14,46k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$32.18
    1 Year Low$4.04
    Open$23.04
    High$23.52
    Low$22.86

    Buy any stock with any amount of money.

    Download the App
    Download the app